Trials
2 active
2 in total · 1 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “One drop of reconstituted DFL24498 will be instilled topically in each eyes 4 times a day (QID) for 12 weeks.”In the company’s words, NCT07503886 on ClinicalTrials.gov
- Tested for
- Atopic Keratoconjunctivitis, Dry Eye Disease (DED)
- Main trialPhase 3
- “This is a phase 3, multicenter, randomized, double-masked, parallel-group, vehicle-controlled study to evaluate the safety and efficacy of DFL24498 compared with vehicle ophthalmic solution, in participants with AKC. The study consists of 2 cohorts: the adult cohort includes approximately 138 participants and the pediatric cohort which includes approximately 15 participants. The cohorts will be randomized separately. Adult participants will be randomized in a 1:1 ratio, while pediatric participants will be randomized in a 2:1 ratio to receive DFL24498 or vehicle.”In the company’s words, NCT07395232 on ClinicalTrials.gov
Other drugs for Atopic Keratoconjunctivitis
- IbrutinibJohnson & Johnson (Janssen) · Phase 3
- AxatilimabIncyte · Syndax Pharmaceuticals · Phase 3
- RovadicitinibChia Tai Tianqing Pharmaceutical Group Co., Ltd. · Phase 2
- Autologous HB-adMSCsHope Biosciences LLC · Phase 2
- TVAX-008Grand Theravac Life Sciences (Nanjing) Co., Ltd. · Phase 1/2
- AHB-171Ausper Biopharma Co., Ltd. · Phase 2
Coming up2
- 27 DecPhase 2 trial completes · ClinicalTrials.gov
- Mar 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | Mar 2027 | An Efficacy and Safety Study of DFL24498 in the Treatment of AKC | |
| Phase 2Recruiting | 27 Dec 2026 | An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026